64 related articles for article (PubMed ID: 22372342)
21. Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients.
Perkins NL; Coughlan EP; Franklin RA; Reid MR; Taylor J
N Z Med J; 1996 Oct; 109(1032):402-5. PubMed ID: 8937391
[TBL] [Abstract][Full Text] [Related]
22. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
Jonsson MK; Levi M; Rudén U; Wahren B
Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of herpes simplex virus type 1 and type 2 among the Indigenous population of Cape York, Far North Queensland, Australia.
Brazzale AG; Russell DB; Cunningham AL; Taylor J; McBride WJ
Sex Health; 2010 Dec; 7(4):453-9. PubMed ID: 21062586
[TBL] [Abstract][Full Text] [Related]
25. [Seroepidemiology of Herpes simplex virus type 2 in the Amerindian Yukpa population of Zulia state, Venezuela].
Monsalve F; Estévez J; Costa L; Salas M; Hernández M; Olaya J; Rodríguez E; Callejas D
Rev Med Chil; 2001 Mar; 129(3):247-52. PubMed ID: 11372290
[TBL] [Abstract][Full Text] [Related]
26. Does offering human immunodeficiency virus testing at the time of blood donation reduce transfusion transmission risk and increase disclosure counseling? Results of a randomized controlled trial, São Paulo, Brazil.
Goncalez TT; Blatyta PF; Santos FM; Montebello S; Esposti SP; Hangai FN; Salles NA; Mendrone A; Truong HM; Sabino EC; McFarland W
Transfusion; 2015 Jun; 55(6):1214-22. PubMed ID: 25646883
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of specific herpes simplex virus-2 antibodies and associated factors in women of a rural town of Colombia.
Sierra CA; Bedoya AM; Paris S; Baena A; Gaviria AM; Rojas CA; Arbelaez MP; Sanchez GI
Trans R Soc Trop Med Hyg; 2011 Apr; 105(4):232-8. PubMed ID: 21353272
[TBL] [Abstract][Full Text] [Related]
28. Sero-prevalence of Herpes simplex virus type 2 (HSV-2) in Rakai district, Uganda.
Emonyi IW; Gray RH; Zenilman J; Schmidt K; Wawer MJ; Sewankambo KN; Serwadda D; Kiwanuka N; Nalugoda F
East Afr Med J; 2000 Aug; 77(8):428-30. PubMed ID: 12862067
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors.
van de Laar MJ; Termorshuizen F; Slomka MJ; van Doornum GJ; Ossewaarde JM; Brown DW; Coutinho RA; van den Hoek JA
Int J Epidemiol; 1998 Feb; 27(1):127-34. PubMed ID: 9563706
[TBL] [Abstract][Full Text] [Related]
30. Sexual behaviour of Croatian blood donors as a threat to the health of blood recipients.
Miskulin M; Puntaric D; Miskulin I; Atalic B; Dijanic T
Blood Transfus; 2011 Oct; 9(4):407-12. PubMed ID: 21839015
[TBL] [Abstract][Full Text] [Related]
31. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations.
Cowan FM; Johnson AM; Ashley R; Corey L; Mindel A
BMJ; 1994 Nov; 309(6965):1325-9. PubMed ID: 7866079
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus type 2 infection as a biomarker for sexual debut among young people in sub-Saharan Africa: a literature review.
Bastien S; Mason-Jones AJ; De Koker P; Mmbaga EJ; Ross DA; Mathews C
Int J STD AIDS; 2012 Nov; 23(11):761-6. PubMed ID: 23155093
[TBL] [Abstract][Full Text] [Related]
33. Disclosure of HSV-2 serological test results in the context of an adolescent HIV prevention trial in Kenya.
Hallfors DD; Cho H; Mbai II; Millimo BW; Atieno C; Okumu D; Luseno WK; Hartman S; Halpern CT; Hobbs MM
Sex Transm Infect; 2015 Sep; 91(6):395-400. PubMed ID: 26139208
[TBL] [Abstract][Full Text] [Related]
34. An evidence based approach to testing for antibody to herpes simplex virus type 2.
Copas AJ; Cowan FM; Cunningham AL; Mindel A
Sex Transm Infect; 2002 Dec; 78(6):430-4. PubMed ID: 12473804
[TBL] [Abstract][Full Text] [Related]
35. Core group approach to identify college students at risk for sexually transmitted infections.
Sánchez-Alemán MA; Conde-Glez CJ; Uribe-Salas F
Rev Saude Publica; 2008 Jun; 42(3):428-36. PubMed ID: 18470365
[TBL] [Abstract][Full Text] [Related]
36. Psychosocial impact of type-specific herpes simplex serological testing on asymptomatic sexual health clinic attendees.
Smith A; Denham I; Keogh L; Jacobs D; McHarg V; Marceglia A; Wood V
Int J STD AIDS; 2000 Jan; 11(1):15-20. PubMed ID: 10667895
[TBL] [Abstract][Full Text] [Related]
37. Human alphaherpesvirus 2 (HSV-2) among female sex workers from Brazil: cross-sectional study using respondent-driven sampling.
Lima LRP; Almeida NAA; Horta MAP; Belo VS; da Silva AS; Capelin GJM; Fernandes FRP; Puga MAM; Rezende GR; Tanaka TSO; Castro LS; Motta-Castro ARC; de Paula VS
Sex Transm Infect; 2021 Sep; 97(6):461-464. PubMed ID: 32938706
[TBL] [Abstract][Full Text] [Related]
38. Limited benefit of repeating a sensitive question in a cross-sectional sexual health study.
Norris Turner A; Paul P; Norris AH
BMC Med Res Methodol; 2013 Mar; 13():34. PubMed ID: 23496958
[TBL] [Abstract][Full Text] [Related]
39. Parents' reactions to testing for herpes simplex virus type 2 as a biomarker of sexual activity in Botswana junior secondary school students.
Cham HJ; Lasswell SM; Miller KS
Sex Health; 2016 Apr; 13(2):148-54. PubMed ID: 26886026
[TBL] [Abstract][Full Text] [Related]
40. Risk behavior in Norwegian blood donors.
Stigum H; Bosnes V; Ørjasaeter H; Heier HE; Magnus P
Transfusion; 2001 Dec; 41(12):1480-5. PubMed ID: 11778060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
